Filing Details

Accession Number:
0001179110-16-021962
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-03-18 19:43:25
Reporting Period:
2016-03-16
Filing Date:
2016-03-18
Accepted Time:
2016-03-18 19:43:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1346830 Cara Therapeutics Inc. CARA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1237624 Martin Vogelbaum 152 West 57Th Street, 23Rd Floor
New York NY 10019
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-03-16 152,273 $4.78 2,820,330 No 4 P Indirect By Partnership
Common Stock Acquisiton 2016-03-17 247,727 $4.93 3,068,057 No 4 P Indirect By Partnership
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Partnership
No 4 P Indirect By Partnership
Footnotes
  1. These securities are owned directly by Rho Ventures VI, L.P. ("RV VI"). RMV VI, L.L.C. ("RMV") is the general partner of RV VI and Rho Capital Partners LLC ("RCP") is the managing member of RMV. Mark Leschly, Habib Kairouz and Joshua Ruch are managing members of RCP and exercise shared voting and investment power with respect to the shares owned by RV VI. The reporting person, a member of the Board of Directors of the issuer, is a non-managing member of RMV and, as such, advises RV VI with respect to voting and investment decisions relating to the shares of stock owned by RV VI but does not have or share voting and investment power over such shares. The reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.